Search

Sanofi SA

Закрыт

СекторЗдравоохранение

86.39 0.51

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

85.6

Макс.

86.45

Ключевые показатели

By Trading Economics

Доход

1.1B

3B

Продажи

2.9B

15B

P/E

Средняя по отрасли

25.373

68.089

Прибыль на акцию

3.55

Рентабельность продаж

19.832

Сотрудники

74,846

EBITDA

957M

5B

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+10.71% upside

Дивиденды

By Acuity

Следующий отчет о доходах

28 янв. 2027 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

6.1B

103B

Предыдущая цена открытия

85.88

Предыдущая цена закрытия

86.39

Sanofi SA График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 нояб. 2026 г., 23:51 UTC

News

Electromed, Inc. reported fiscal Q1 2027 revenues of $18.7 million, missing analyst expectations of $19.27 million, while EPS of $0.32 exceeded estimates by $0.03.

10 нояб. 2026 г., 23:51 UTC

Correlated Moves
News

Seagate Technology Holdings PLC launched the FireCuda Forge, its first hard drive using the Alkemi platform, targeting gamers and content creators.

10 нояб. 2026 г., 23:51 UTC

News

Legend Biotech reported Q3 2026 net trade sales of CARVYKTI at approximately $710 million, with adjusted net income of $55.6 million, advancing in after-market trading.

10 нояб. 2026 г., 23:46 UTC

News

Timothy I. McGuire will resign from the Dollar General Corporation Board of Directors effective December 3, 2026, for personal reasons.

10 нояб. 2026 г., 23:42 UTC

News
Correlated Moves

Jefferies maintains Buy rating on Onto Innovation, lowering price target to $350 while expressing confidence in the company's growth prospects.

10 нояб. 2026 г., 23:41 UTC

News

KORU Medical Systems reports Q3 adjusted EPS of $0.02 and net revenues of $11.6 million, revising full-year guidance to $48.0M-$48.5M.

10 нояб. 2026 г., 23:41 UTC

Social Media
Correlated Moves
News

MARA Holdings, Inc. shares are trading modestly lower during after-market hours, following fluctuations earlier in the session and amid a decline in Bitcoin prices.

10 нояб. 2026 г., 23:36 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices reported record data center revenue of $8.5 billion for Q3, with shares trading modestly higher in after-market hours.

10 нояб. 2026 г., 23:31 UTC

News

Barrick Mining Corporation filed for an IPO of its North American gold assets, targeting a $1.25 billion annualized base dividend for American Barrick Gold Corporation.

10 нояб. 2026 г., 23:31 UTC

News

UBS maintains a Neutral rating on Qualys and raises its price target to $210, while Jefferies lowers its target to $215.

10 нояб. 2026 г., 23:21 UTC

Social Media
News

Meta Platforms, Inc. shares closed modestly higher during after-market hours, extending their winning streak to three days amid broader market gains.

10 нояб. 2026 г., 23:21 UTC

Social Media
News

NVIDIA Corporation is under investigation by former U.S. Attorney Joon H. Kim regarding CEO Jensen Huang's position, as shares gain modestly in after-hours trading.

10 нояб. 2026 г., 23:21 UTC

News

DraftKings Inc. shares advanced in after-market trading amid reports of a CFTC probe into Kalshi, a company linked to the betting industry.

10 нояб. 2026 г., 23:16 UTC

News

Mercury Systems Inc reported record bookings of $370 million and revenue of approximately $253 million for Q1 fiscal 2027, despite a cash flow deficit.

10 нояб. 2026 г., 23:16 UTC

News

Royal Gold, Inc. will participate in the Renmark Financial Communications Virtual Non-Deal Roadshow on November 24, 2026, featuring insights from Alistair Baker.

10 нояб. 2026 г., 23:12 UTC

News

Dynex Capital, Inc. declared a cash dividend of $0.17 per share for November 2026, payable on December 1, 2026, to shareholders of record as of November 23, 2026.

10 нояб. 2026 г., 23:06 UTC

Social Media
News

Peloton Interactive upsized its offering of senior secured notes to $700 million, aiming to repay term loans under its $1 billion facility.

10 нояб. 2026 г., 23:06 UTC

Correlated Moves
Macro Event
News

USD/PLN exchange rate is modestly higher, influenced by October's U.S. CPI data showing a 0.4% month-over-month increase, raising interest rate hike concerns.

10 нояб. 2026 г., 23:06 UTC

Macro Event
Correlated Moves
News

USD/DKK trades modestly higher since Monday's close.

10 нояб. 2026 г., 23:06 UTC

News

BlackRock's private credit fund has launched a tender offer to buy up to 3.41 million shares, according to an SEC filing.

10 нояб. 2026 г., 23:02 UTC

News
Social Media

Fossil Group Inc reported Q3 net sales of $271.2 million and raised full-year sales guidance to between $980 million and $990 million.

10 нояб. 2026 г., 23:02 UTC

News

B&G Foods reports Q3 adjusted EPS of $0.21 and net sales of $459.8 million, raising full-year sales guidance to $1.760B-$1.800B.

10 нояб. 2026 г., 23:02 UTC

News
Social Media

Costco announces a special cash dividend of $30 per share, totaling approximately $13.3 billion, payable on December 4, 2026.

10 нояб. 2026 г., 23:02 UTC

News

Accelerated share repurchase agreement for $600 million announced.

10 нояб. 2026 г., 23:02 UTC

News

Gladstone Land Corporation reports Q3 2026 net income of $11.0 million, with FFO of $15.1 million, exceeding expectations and driven by strong crop pricing.

10 нояб. 2026 г., 23:02 UTC

Event
News

Alcon AG reported Q3 2026 net sales of $2.7 billion, missing estimates, and narrowed its full-year guidance, raising investor concerns.

10 нояб. 2026 г., 23:02 UTC

Social Media
News

Kura Oncology reported strong Q3 2026 results, with net product revenue from KOMZIFTI rising significantly and a narrower net loss than expected.

10 нояб. 2026 г., 23:02 UTC

Correlated Moves
Macro Event
News

U.S. CPI for October rises, increasing speculation on Fed rate hikes.

10 нояб. 2026 г., 23:01 UTC

News

Burlington Stores, Inc. will release its Q3 fiscal year 2026 earnings on November 24, 2026, before the market opens, with a conference call at 8:30 a.m. ET.

10 нояб. 2026 г., 23:01 UTC

News

GoPro Inc will not file its Form 10-Q on time, citing financial close procedures and covenant breaches, with expected net revenue of $96 million.

Сравнение c конкурентами

Изменение цены

Sanofi SA Прогноз

Целевая цена

By TipRanks

10.71% рост

Прогноз на 12 месяцев

Средняя 95.154 EUR  10.71%

Максимум 110 EUR

Минимум 80 EUR

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для Sanofi SA на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

14 ratings

8

Покупка

6

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat